Position in GILD
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$559,559
-$58,546 QoQ
Shares Held
4,429
-0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,328
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DRIVE WEALTH MANAGEMENT, LLC holds $10,951,159 across 10 Drug Manufacturers - General names. GILD ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,080 | $3,694,244 | |
| 2 | ABBV |
AbbVie Inc.
|
6,804 | $1,712,158 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,904 | $1,401,164 | |
| 4 | JNJ |
Johnson & Johnson
|
4,782 | $1,214,484 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
14,082 | $811,404 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
4,429 | $559,559 | |
| 7 | AMGN |
Amgen Inc
|
1,537 | $556,577 | |
| 8 | AZN |
Astrazeneca PLC
|
2,156 | $408,820 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $559,559 | 4,429 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $618,105 | 4,435 | Shares | Other | 2026-04-14 | |
| 2025-12-31 | $535,268 | 4,361 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $468,198 | 4,218 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $517,984 | 4,672 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $406,068 | 3,624 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $289,949 | 3,139 | Shares | Sole | 2025-01-22 | |
| No filing history on record for this holder in this stock. | ||||||